InvestorsHub Logo
Followers 37
Posts 2947
Boards Moderated 0
Alias Born 12/24/2011

Re: Cherry post# 841

Friday, 09/21/2018 6:34:59 PM

Friday, September 21, 2018 6:34:59 PM

Post# of 1454
Not really. They clinical phase 2 report was not as expected. The stock had been climbing this year and even had a projected value of $45. Insiders had been purchasing since May at $14 or higher.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCT News